Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?

• Status: Unknown status
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary aim of the study was to test if the administration of Hyoscine Butyl Bromide, at time of caecal intubation, increases the adenoma detection rate.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Valduce Hospital
• Treatments: Bromides; Butylscopolammonium Bromide; Scopolamine; Scopolamine Hydrobromide

Criteria

Inclusion Criteria:

• outpatients referred for colonoscopy

Exclusion Criteria:

• glaucoma

• benign prostatic hyperplasia or urinary obstruction

• previous intestinal resection,

• ongoing therapy with tricyclic antidepressants

• chronic renal failure

• history of IBD

• participation other studies

• unsedated colonoscopy